Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Marburg
Clinical trial register · Germany

Clinical Trials in Marburg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5081 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
5081
Studies in scope
all four open statuses
2880
Recruiting now
open to new participants
985
Lead sponsors
across recruiting studies
Top sites
Berlin 1591 Hamburg 896 Essen 767 Dresden 717 Heidelberg 626
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca7 Philipps University Marburg7 Merck Sharp & Dohme LLC4 Bristol-Myers Squibb4 Novartis Pharmaceuticals4 AbbVie2 Janssen Research & Development, LLC2 Teva Branded Pharmaceutical Products R&D LLC2 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2 Hoffmann-La Roche2 Biohaven Therapeutics Ltd.2 University Hospital Heidelberg2 Eli Lilly and Company2 UCB Biopharma SRL2 Genmab2 Xenon Pharmaceuticals Inc.2 Exelixis2 AvenCell Therapeutics, Inc.2 Takeda2 Amicus Therapeutics1 Nocion Therapeutics1 Eisai Inc.1 Maria Joyera Rodríguez1 Bielefeld University1 Dompé Farmaceutici S.p.A1 Show all 66
Site location
Berlin1591 Hamburg896 Essen767 Dresden717 Heidelberg626 Cologne619 Leipzig515 München513 Hanover488 Tübingen457 Bonn424 Düsseldorf409 Munich398 Freiburg im Breisgau392 Erlangen373 Frankfurt369 Münster359 Frankfurt am Main346 Ulm343 Mainz336 Würzburg299 Aachen267 Augsburg248 Kiel236 Lübeck225 Show all 642
All 642 locations
Target enrolment
to

Trials with a site in Marburg

101 of 5081 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Heinrich-Heine University, Duesseldorf
Not applicable
171
Ulm, Würzburg, Hamburg, Marburg, Cologne, Düsseldorf, Wuppertal, Dresden
2027-01
Recruiting
Akeso
Phase 3
900
Essen, Frankfurt, Mainz, Marburg
2026-09-24
Recruiting
Bristol-Myers Squibb
Phase 2
160
Stuttgart, Marburg, Homburg, Cologne, Halle, Hessen
2026-09-10
Recruiting
AstraZeneca
Phase 3
1,072
Berlin, Dresden, Essen, Freiburg im Breisgau, Hanover, Kiel, Mainz, Marburg
2026-08-31
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
150
Erlangen, Frankfurt am Main, Marburg, Cologne, Düsseldorf, Homburg, Berlin
2026-06-02
Recruiting
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
NCT07645443Delusional Disorder, Brief Psychotic Disorder, Schizophreniform Disorder, Schizophrenia / Schizoaffective Disorder
Stephanie Mehl
Not applicable
252
Mannheim, Augsburg, München, Hamburg, Marburg, Cologne, Berlin
2026-05-27
Recruiting
Unveiling Maternal-fetal BRAin-body Interactions in Pregnant WOmen Affected by Depression
NCT07932093Depression in Pregnancy, Major Depressive Disorder, Pregnancy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
720
Marburg
2026-04-29
Recruiting
Wuerzburg University Hospital
Not applicable
200
Würzburg, Erlangen, Hamburg, Hattingen, Marburg, Nuremberg
2026-04-10
Recruiting
Eisai Inc.
Phase 2
64
Bayern, Berlin, Marburg, Schwerin
2026-03-26
Recruiting
Eli Lilly and Company
Phase 3
800
Bamberg, Berlin, Essen, Hanover, Karlsruhe, Marburg, Oldenburg, Schwerin
2026-02-10
Active, closed
A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
NCT07042620Brain Tumor Adult, Low Grade Glioma (LGG), High Grade Glioma (HGG), Glioblastoma
SonoClear AS
Not applicable
15
Günzburg, Marburg, Tübingen, Villingen-Schwenningen
2026-02-09
Recruiting
T-cell Therapy in Patients With PML
NCT06990087Progressive Multifocal Leucoencephalopathy (PML)
Hannover Medical School
Phase 2
23
München, Marburg, Hanover, Bonn, Düsseldorf, Essen, Kiel
2026-02-06
Not yet open
Goethe University
Phase 4
90
Frankfurt, Marburg
2026-02
By invitation
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
NCT07474051B-cell Lymphoma, Chronic Lymphocytic Leukemia, Hematologic Malignancy, AML (Acute Myelogenous Leukemia)
DrugAllo-QuadCAR01-T
AvenCell Therapeutics, Inc.
Observational
178
Berlin, Dresden, Marburg, Munich, Ulm
2026-01-29
Recruiting
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
NCT07284433Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma, Leukemia Relapse, Lymphoma Receiving CAR-T Therapy
DrugAllo-QuadCAR01-T
AvenCell Therapeutics, Inc.
Phase 1/2
178
Ulm, Erlangen, Munich, Marburg, Essen, Dresden, Berlin, Hamburg
2026-01-06
Recruiting
Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Adolescents - A Validation Study in Switzerland and Germany
NCT07368166PTSD - Post Traumatic Stress Disorder, PTSD-Related Functional Impairment in Children and Adolescents
University Children's Hospital, Zurich
Observational
1,200
Aachen, Bamberg, Eichstätt, Konstanz, Marburg, Oldenburg, Ulm
2025-12-15
Recruiting
AbbVie
Phase 2/3
490
Heidelberg, Würzburg, Marburg, Cologne, Jena, Hamburg
2025-12-10
Active, closed
iVascular S.L.U.
Not applicable
57
Bonn, Kiel, Marburg, Nuremberg, Recklinghausen
2025-11-27
Recruiting
Enhancing Generalization of Virtual Reality Exposure for Public Speaking Anxiety
NCT07323498Public Speaking Anxiety, Public Speaking Fear
Philipps University Marburg
Not applicable
48
Marburg
2025-11-26
Recruiting
AbbVie
Phase 2
180
Immenhausen, Marburg, Berlin
2025-11-25
Active, closed
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
Hamburg, Marburg
2025-11-19
Recruiting
Pfizer
Phase 2
200
Stuttgart, Münster, Berlin, Dresden, Leipzig, Marburg, Wuppertal
2025-10-30
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
NCT06659445Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
DrugAvacincaptad Pegol
ONL Therapeutics
Phase 2
324
Ahaus, Bonn, Düsseldorf, Frankfurt am Main, Marburg, Würzburg
2025-10-28
Recruiting
University Hospital Tuebingen
Phase 3
150
Saarlouis, Berlin, Bottrop, Dresden, Marburg, Tübingen, Wolfach
2025-10-27
Recruiting
Philipps University Marburg
Not applicable
150
Marburg
2025-10-13
Recruiting
A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
NCT07181369Healthy Subjects, Cold Urticaria, Symptomatic Dermographism, Chronic Inducible Urticaria
Granular Therapeutics Limited
Phase 1
72
Berlin, Halle, Marburg, Münster
2025-10-06
Recruiting
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
200
Dresden, Düsseldorf, Kassel, Marburg, München, Münster
2025-09-30
Recruiting
Hoffmann-La Roche
Phase 2
120
Berlin, Dresden, Essen, Heidelberg, Marburg, Paderborn, Schwerin
2025-09-09
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Berlin, Erlangen, Essen, Mainz, Marburg, Tübingen, Würzburg
2025-07-21
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Marburg, Berlin, Bochum, Erbach im Odenwald, Essen, Greifswald, Heidelberg, Münster
2025-06-23
Recruiting
Ecological Momentary Intervention for Reward in Anhedonia
NCT07155941Anhedonia, Anxiety, Stress, Depression
Philipps University Marburg
Not applicable
60
Marburg
2025-06-18
Recruiting
Takeda
Phase 3
59
Mannheim, Ulm, Marburg, Hanover, Berlin
2025-05-06
Recruiting
Takeda
Observational
30
Rüdersdorf, Marburg, Bochum, Berlin
2025-04-29
By invitation
Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy
NCT06968897SARS CoV-2, Developmental Disorder, Pregnancy Related
Philipps University Marburg
Observational
250
Marburg
2025-04-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
683
Berlin, Marburg
2025-03-31
Recruiting
Daiichi Sankyo
Phase 3
582
Berlin, Bonn, Detmold, Hamburg, Heilbronn, Jena, Mannheim, Marburg
2025-03-19
Recruiting
AstraZeneca
Phase 3
990
Bendorf, Berlin, Haltern am See, Hanover, Immenhausen, Lübeck, Marburg, Rosenheim
2025-03-18
Active, closed
AstraZeneca
Phase 2
82
Berlin, Dresden, Essen, Hamburg, Marburg
2025-03-12
Active, closed
POROUS GmbH
Not applicable
1,600
Berlin, Halle, Marburg
2025-03-03
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
8,000
Cologne, Heidelberg, Marburg
2025-03-01
Recruiting
Maria Joyera Rodríguez
Phase 4
135
Marburg
2025-02-12
By invitation
Gemini Eye Clinic
Observational
100
Marburg
2025-01-01
Active, closed
AstraZeneca
Phase 3
181
Marburg, Tübingen, Villingen-Schwenningen, Wiesbaden
2024-12-03
Recruiting
Pediatric Intensive Care Transport Registry
NCT07070258Critical Care Medicine, Transportation of Patients, Pediatrics
Philipps University Marburg
Observational
1,000
Dresden, Marburg
2024-11-25
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Ulm, Berlin, Frankfurt am Main, Marburg, Göttingen, Neubrandenburg, Bonn, Düsseldorf
2024-10-30
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Esslingen am Neckar, Ulm, Kempten (Allgäu), München, Marburg, Hanover, Dortmund, Herne
2024-10-07
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Beelitz, Dresden, Düsseldorf, Kassel, Leipzig, Marburg, München, Münster
2024-10-02
Active, closed
Nocion Therapeutics
Phase 2
455
Munich, Darmstadt, Frankfurt am Main, Marburg, Halle, Geesthacht, Lübeck, Berlin
2024-09-24
Recruiting
University of Kiel
Not applicable
60
Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte
2024-09-05
Recruiting
STIMPulseControl Ancillary Speech Study
NCT06561919Parkinson Disease, Impulse Control Disorder
Steffen Paschen
Not applicable
60
Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte
2024-09-05
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Freiburg im Breisgau, Kehl, Ulm, Erlangen, München, Bernau bei Berlin, Marburg, Osnabrück
2024-07-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Heidelberg, Heilbronn, Schwäbisch Hall, Munich, Marburg, Düsseldorf, Essen, Worms
2024-07-24
Recruiting
Bielefeld University
Not applicable
40
Bielefeld, Marburg
2024-07-09
Active, closed
AskBio Inc
Phase 2
59
Berlin, Marburg, Tübingen, Würzburg
2024-06-11
Recruiting
Philipps University Marburg
Not applicable
40
Marburg
2024-05-28
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Freiburg im Breisgau, Kehl, Ulm, Erlangen, Bernau bei Berlin, Marburg, Osnabrück, Bielefeld
2024-05-13
Active, closed
Eli Lilly and Company
Phase 3
450
Berlin, Dresden, Frankfurt am Main, Heidelberg, Marburg, Weisbaden
2024-04-26
Active, closed
AstraZeneca
Phase 3
594
Berlin, Frankfurt, Göttingen, Hamburg, Heidelberg, Heilbronn, Leipzig, Marburg
2024-03-04
Recruiting
Amicus Therapeutics
Observational
500
Bochum, Höchheim, Marburg, München, Ulm
2024-02-16
Recruiting
Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies (1b Dose Expansion)
NCT05949125Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
AvenCell Europe GmbH
Phase 1
37
Ulm, Munich, Würzburg, Marburg, Dresden, Berlin, Cologne, Essen
2024-01-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Freiburg im Breisgau, Heidelberg, Nürtingen, Munich, Regensburg, Marburg, Göttingen, Bergisch Gladbach
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
München, Nuremberg, Marburg, Hanover, Moers, Münster, Mainz, Großhansdorf
2023-12-15
Active, closed
Amgen
Phase 3
633
Frankfurt am Main, Marburg, Cologne
2023-11-02
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Freiburg I. Breisgau, Munich, Münnerstadt, Hamburg, Immenhausen, Marburg, Essen, Cologne
2023-09-14
Recruiting
Improving Low ASPECTS Stroke Thrombectomy
NCT04862507Acute Ischemic Stroke
Universitätsklinikum Hamburg-Eppendorf
Observational
500
Berlin, Bremen, Hamburg, Kaiserslautern, Marburg, Münster, Rostock
2023-05-01
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Aachen, Bielefeld, Frankfurt, Freiburg im Breisgau, Marburg, München, Ulm
2023-04-25
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Cottbus, Dresden, Greifswald, Hamburg, Heidelberg, Marburg, Tübingen, Ulm
2023-03-29
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Aachen, Berlin, Bielefeld, Frankfurt, Freiburg im Breisgau, Marburg, München, Radeberg
2023-02-14
Recruiting
AstraZeneca
Phase 3
3,527
Augsburg, Berlin, Cologne, Hamburg, Hanover, Kiel, Leverkusen, Marburg
2022-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Munich, Marburg, Bramsche, Göttingen, Merzig, Dresden, Leipzig, Halle
2022-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Freiburg im Breisgau, Mannheim, Munich, Würzburg, Frankfurt am Main, Marburg, Paderborn, Velbert
2022-11-21
Recruiting
The CATALINA Study
NCT05008081Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens
Observational
1,000
Großhansdorf, Itzehoe, Kiel, Marburg
2022-10-25
Active, closed
Genmab
Phase 1
17
Erlangen, Marburg, Münster
2022-10-04
Recruiting
Philipps University Marburg
Phase 1/2
80
Marburg
2022-09-23
Recruiting
Celgene
Phase 3
810
München, Traunstein, Weiden, Marburg, Hanover, Bonn, Düsseldorf, Kiel
2022-09-20
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 1
40
Ulm, Düsseldorf, Göttingen, Hanover, Marburg, München
2022-07-21
Active, closed
Genmab
Phase 2
264
Ulm, Augsburg, Regensburg, Würzburg, Marburg, Leipzig
2022-06-14
Recruiting
Zimmer Biomet
Observational
500
Marburg, Leipzig, Regensburg
2022-04-11
Recruiting
Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps
Observational
300
Berlin, Dessau, Hamburg, Leipzig, Marburg, Münster, Rotenburg (Wümme)
2022-02-28
By invitation
UCB Biopharma SRL
Phase 3
300
Berlin, Bielefeld, Erlangen, Frankfurt am Main, Marburg
2022-02-03
Recruiting
UCB Biopharma SRL
Phase 3
350
Aachen, Berlin, Bielefeld, Erlangen, Frankfurt am Main, Kehl-kork, Marburg, München
2021-12-07
Recruiting
A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients
NCT04996433Persistent Depressive Disorder, Treatment-resistant Depression
University of Greifswald
Not applicable
396
Berlin, Bonn, Hanover, Jena, Lübeck, Marburg, München, Tübingen
2021-12-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Munich, Marburg, Essen, Dresden, Magdeburg, Berlin, Hamburg
2021-06-25
Recruiting
University Hospital Heidelberg
Not applicable
326
Heidelberg, Marburg, Stuttgart
2021-04-19
Active, closed
Combination of Ranibizumab and Targeted Laser Photocoagulation
NCT04444492Central Retinal Vein Occlusion With Macular Edema
DrugsLucentis·Ranibizumab
University of Giessen
Phase 3
88
Freiburg im Breisgau, Giessen, Hanover, Leipzig, Ludwigshafen, Marburg, München, Münster
2020-08-25
Recruiting
University Hospital Heidelberg
Not applicable
72
Heidelberg, Marburg
2020-08-25
Active, closed
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
NCT03947619ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Abiomed Inc.
Not applicable
527
Würzburg, Düsseldorf, Essen, Trier, Dresden, Jena, Marburg, Zwickau
2019-12-12
Recruiting
Boston Scientific Corporation
Observational
500
Cologne, Düsseldorf, Essen, Kiel, Marburg, Oldenburg, Würzburg
2019-10-23
Active, closed
Bristol-Myers Squibb
Phase 3
839
Dresden, Essen, Hamburg, Hanover, Heidelberg, Marburg, Munich
2019-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Munich, Neuburg A.d. Donau, Unterhaching, Marburg, Cologne, Dresden, Leipzig, Barsinghausen
2018-12-28
Active, closed
Exelixis
Phase 3
187
Tübingen, Würzburg, Marburg, Hanover, Dresden, Magdeburg, Aachen, Bonn
2018-10-05
Active, closed
AstraZeneca
Phase 3
1,018
Berlin, Cologne, Duisburg, Hanover, Heidelberg, Marburg, Mettmann, Mühlheim An Der Ruhr
2018-05-14
Recruiting
University Hospital Marburg
Observational
1,000
Marburg
2018-03-01
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
DrugsVusolimogene Oderparepvec·Opdivo·Nivolumab
Replimune, Inc.
Phase 2
340
Berlin, Essen, Kiel, Marburg
2017-09-20
Active, closed
Hoffmann-La Roche
Phase 2
316
Berlin, Düsseldorf, Kassel, Leipzig, Marburg, München, Tübingen, Ulm
2017-06-27
Active, closed
ITM Solucin GmbH
Phase 3
324
Bad Berka, Berlin, Bonn, Erlangen, Essen, Hamburg, Magdeburg, Marburg
2017-02-02
Recruiting
Technische Universität Dresden
Not applicable
555
Dresden, Marburg
2016-07
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Dresden, Berlin, Düsseldorf, Essen, Hamburg, Heidelberg, Koblenz, Marburg
2015-08-06
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Berlin, Dresden, Essen, Giessen, Heidelberg, Homburg/Saar, Magdeburg, Marburg
2013-09-09
Recruiting
Pediatric Arm of DZL All Age Asthma Cohort
NCT02496468Asthma, Wheeze, Hypersensitivity, Endophenotype
LMU Klinikum
Observational
1,500
Cologne, Hanover, Lübeck, Marburg, Munich
2013-01
Recruiting
International (Pediatric) Peritoneal Biobank
NCT01893710Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy
Heidelberg University
Observational
500
Heidelberg, Berlin, Cologne, Essen, Hamburg, Marburg
2011-02-01
Rows per page Showing 1–101 of 101
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-germany/city/marburg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,081 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 101 of those studies with a site in Marburg.

How many clinical trials are recruiting in Marburg?

60 of the 101 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 32 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Marburg), 101 studies
PhaseStudiesRecruitingShare
Phase 3371736.6%
Not applicable191418.8%
Observational171316.8%
Phase 217816.8%
Phase 1434%
Phase 2/3323%
Phase 1/2222%
Phase 4212%

Most active sponsors

Lead sponsors with the most studies (Marburg)
Lead sponsorStudiesRecruiting
AstraZeneca73
Philipps University Marburg76
Bristol-Myers Squibb42
Merck Sharp & Dohme LLC42
Novartis Pharmaceuticals41
AbbVie22
AvenCell Therapeutics, Inc.21
Biohaven Therapeutics Ltd.20
Eli Lilly and Company21
Exelixis21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.